Sanofi-Aventis, Allegra 120mg 30 Sanofi-Aventis

Allegra Active ingredient – fexofenadine hydrochloride 120/180mg
Indications
Seasonal allergic rhinitis (to reduce symptoms) – 120 mg tablets.
chronic idiopathic urticaria (to reduce symptoms) – 180 mg tablets.
Method of administration – Orally, before meals.
Seasonal allergic rhinitis: the recommended dose for adults and children 12 years and older is 120 mg once a day.
Chronic idiopathic urticaria: the recommended dose for adults and children 12 years and older is 180 mg once a day.
Patients at risk. Studies in special risk groups (elderly patients, with renal and hepatic insufficiency) have shown that no dosage adjustment is required for patients in these categories.
Contraindications
Hypersensitivity to fexofenadine or any of the excipients of the drug;
With caution in patients with chronic renal and hepatic insufficiency, as well as in elderly patients (lack of clinical experience of use in this category of patients); in patients with cardiovascular diseases, including in the anamnesis (antihistamines can cause palpitations and tachycardia
Contraindications – hypersensitivity to fexofenadine or any of the excipients of the drug, pregnancy, breastfeeding period,
childhood (up to 12 years).
Side effects – include headache, drowsiness, dizziness and nausea